MARKET

EBS

EBS

Emergent Biosolutions Inc
NYSE
5.65
-0.71
-11.16%
After Hours: 5.78 +0.13 +2.30% 19:58 05/09 EDT
OPEN
6.31
PREV CLOSE
6.36
HIGH
6.36
LOW
5.64
VOLUME
1.97M
TURNOVER
--
52 WEEK HIGH
15.10
52 WEEK LOW
3.840
MARKET CAP
307.93M
P/E (TTM)
-1.5711
1D
5D
1M
3M
1Y
5Y
1D
Emergent BioSolutions: Strong Q1 Performance and Strategic Growth Drive Buy Rating
TipRanks · 17h ago
Emergent BioSolutions’ Earnings Call: A Balanced Outlook
TipRanks · 1d ago
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 1d ago
Emergent BioSolutions rises 22.4%
TipRanks · 1d ago
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 1d ago
Emergent BioSolutions Reports Strong Q1 2025 Earnings
TipRanks · 2d ago
Emergent biosolutions reaffirms 2025 revenue guidance of $750M-$850M amid turnaround progress
Seeking Alpha · 2d ago
Emergent Biosolutions (EBS) Q1 Earnings Top Estimates
NASDAQ · 2d ago
More
About EBS
More
Emergent BioSolutions, Inc. is a life sciences company. It is focused on providing preparedness and response solutions addressing accidental, deliberate and naturally occurring public health threats. Its solutions include a product portfolio, a product development portfolio, and a contract development and manufacturing services portfolio. Its segments include Commercial Products, MCM Products, and Services segment. Its Commercial Product segment consists of NARCAN Nasal Spray. Its MCM Products segment consists of Anthrax MCM products, Smallpox MCM products and Other Products. Its Services segment consists of its Bioservices portfolio. NARCAN (naloxone HCl) Nasal Spray, an intranasal formulation of naloxone, is developed for the emergency treatment of known or suspected opioid overdose as manifested by respiratory and central nervous system depression. Its Bioservices consist of development services, bulk drug substance manufacturing, fill, finish, and packaging of final drug products.
Recently
Symbol
Price
%Change

Webull offers Emergent Biosolutions Inc stock information, including NYSE: EBS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, EBS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading EBS stock methods without spending real money on the virtual paper trading platform.